BACKGROUND/AIMS: Measurement of health related quality of life (HRQoL) is a new tool to evaluate patients with inflammatory bowel disease (IBD). The aims of this study were to verify reliability and responsiveness of a disease-specific questionnaire [Italian Questionnaire on Quality of Life (IQQoL)], and to assess the relationship between clinical and demographic variables and HRQoL in IBD patients. METHODOLOGY: The IQQoL was submitted to all IBD patients consecutively seen at eight participating Hospitals, and re-administered at follow-up visits. The IQQoL covers intestinal and systemic symptoms, emotional and social function. The higher the score, the worse the HRQoL. RESULTS: 249 patients were enrolled, 106 with Crohn's disease (CD) and 143 with ulcerative colitis (UC). IQQoL was re-administered to 134 patients: 98 with unchanged, 17 with worsened and 19 with improved disease activity. The IQQoL was stable over time in patients with stable clinical conditions, and very responsive to change both in patients with improved and worsened disease activity. HRQoL was inversely correlated with disease activity, both in CD and UC. Perception of HRQoL was significantly worse in women than in men. CONCLUSIONS: The IQQoL is a reliable and responsive instrument to assess HRQoL in IBD patients. Active disease is related to poor HRQoL perception. In CD, women, mainly if young, have a worse HRQoL perception than men.
BACKGROUND/AIMS: Measurement of health related quality of life (HRQoL) is a new tool to evaluate patients with inflammatory bowel disease (IBD). The aims of this study were to verify reliability and responsiveness of a disease-specific questionnaire [Italian Questionnaire on Quality of Life (IQQoL)], and to assess the relationship between clinical and demographic variables and HRQoL in IBDpatients. METHODOLOGY: The IQQoL was submitted to all IBDpatients consecutively seen at eight participating Hospitals, and re-administered at follow-up visits. The IQQoL covers intestinal and systemic symptoms, emotional and social function. The higher the score, the worse the HRQoL. RESULTS: 249 patients were enrolled, 106 with Crohn's disease (CD) and 143 with ulcerative colitis (UC). IQQoL was re-administered to 134 patients: 98 with unchanged, 17 with worsened and 19 with improved disease activity. The IQQoL was stable over time in patients with stable clinical conditions, and very responsive to change both in patients with improved and worsened disease activity. HRQoL was inversely correlated with disease activity, both in CD and UC. Perception of HRQoL was significantly worse in women than in men. CONCLUSIONS: The IQQoL is a reliable and responsive instrument to assess HRQoL in IBDpatients. Active disease is related to poor HRQoL perception. In CD, women, mainly if young, have a worse HRQoL perception than men.
Authors: Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh Journal: Can J Gastroenterol Date: 2012-11 Impact factor: 3.522
Authors: Anja Schirbel; Anne Reichert; Stephanie Roll; Daniel C Baumgart; Carsten Büning; Bianca Wittig; Bertram Wiedenmann; Axel Dignass; Andreas Sturm Journal: World J Gastroenterol Date: 2010-07-07 Impact factor: 5.742
Authors: David T Rubin; Marla C Dubinsky; Remo Panaccione; Corey A Siegel; David G Binion; Sunanda V Kane; Joseph Hopper Journal: Dig Dis Sci Date: 2009-09-04 Impact factor: 3.199
Authors: Ashwin N Ananthakrishnan; Vivian S Gainer; Tianxi Cai; Raul Guzman Perez; Su-Chun Cheng; Guergana Savova; Pei Chen; Peter Szolovits; Zongqi Xia; Philip L De Jager; Stanley Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Roy H Perlis; Robert M Plenge; Shawn N Murphy; Katherine P Liao Journal: Am J Gastroenterol Date: 2013-01-22 Impact factor: 10.864
Authors: Salim K Mujais; Ken Story; John Brouillette; Tomoko Takano; Steven Soroka; Catherine Franek; David Mendelssohn; Frederic O Finkelstein Journal: Clin J Am Soc Nephrol Date: 2009-07-30 Impact factor: 8.237
Authors: Aaron B Cohen; Dale Lee; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler; James D Lewis Journal: Dig Dis Sci Date: 2012-08-26 Impact factor: 3.199
Authors: Aoife O'Donovan; Beth E Cohen; Karen H Seal; Dan Bertenthal; Mary Margaretten; Kristen Nishimi; Thomas C Neylan Journal: Biol Psychiatry Date: 2014-06-28 Impact factor: 13.382
Authors: Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro Journal: Front Immunol Date: 2013-09-17 Impact factor: 7.561